<DOC>
	<DOC>NCT01543854</DOC>
	<brief_summary>This study will assess the hemodynamic effect of RLX030 infusion in subjects with acute heart failure. In addition safety and effects on renal function and biomarkers will be assessed.</brief_summary>
	<brief_title>Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients hospitalized or requiring admission to hospital for management of acute heart failure within the previous 48 hours. Pulmonary wedge pressure above or equal to18 mmHg determined by right heart catheterization Systolic blood pressure below 115 mmHg Significant valvular diseases or arrythmias Acute coronary syndrome in previous 45 days Treatment with mechanical support (intraaortic balloon pump, endotracheal intubation, mechanical ventilation, or any ventricular assist device) Impaired renal or hepatic function Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>87 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>RLX030</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>